Platelet component safety in the era of new advancements in bacterial screening and pathogen reduction: A congress report of the 2024 ISBT Transfusion‐Transmitted Infectious Diseases Working Party, Bacteria Subgroup
Vox Sanguinis · 2025-08 · 120 (8) · 846-857
DOI: 10.1111/vox.70053 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vox Sanguinis, online erschienen am 08.06.2025. Verfasst von Michel-Andrés García-Otálora und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine and Health Science, Public Health Research Group, Universidad del Rosario, Bogotá, Colombia. Hauptthemen laut MEDLINE: Blood Safety, Blood Platelets, Platelet Transfusion. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background and Objectives High‐income countries have successfully enhanced platelet component (PC) safety with the implementation of mitigation strategies including donor screening, skin disinfection, first aliquot diversion and PC bacterial screening or treatment with pathogen reduction technologies (PRT). This review discusses the experiences of several institutions with the adoption of bacterial screening methods and/or PRT and highlights residual safety risks. Materials and Methods Data from the American Red Cross (ARC), Australian Red Cross Lifeblood (Lifeblood), Canadian Blood Services (CBS), the Établissement Français du Sang (EFS) and National Health Service Blood and Transplant (NHSBT) were presented at the International Society of Blood Transfusion (ISBT) Congress, Transfusion‐Transmitted Infectious Diseases meeting (Barcelona, June 2024) and were summarised in this report.
Results
PC screening with the automated BACT/ALERT culture system began in 2004 in the ARC and CBS, while the system was adopted in 2008 and 2011 by Lifeblood and NHSBT, respectively. Implementation of PC treatment with the PRT INTERCEPT started in 2016, 2022, and 2006 in the ARC, CBS, and EFS, correspondingly.
Conclusions
PC screening and PC treatment with PRT have significantly increased product safety. However, there are still residual safety risks posed by challenging organisms such as sporulated Bacillus spp. and toxin‐producing Staphylococcus aureus .
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Medicine and Health Science, Public Health Research Group, Universidad del Rosario, Bogotá, Colombia.
- Retired, National Health Service Blood and Transplant, London, UK.
- Microbiology Services Laboratory, National Health Service Blood and Transplant, London, UK.
- Clinical Research, American Red Cross, Rockville, Maryland, USA.
- Donor and Product Safety Policy Unit, Australian Red Cross Lifeblood, West Melbourne, Victoria, Australia.
- Etablissement Français du Sang Grand Est, Boulevard Lobau, Nancy, France.
ORCID-Profile: Carl McDonald, Bethany Brown, Anthea Cheng, Pierre Tiberghien, Sandra Ramirez-Arcos
Zitieren
APA
García-Otálora, M. A., McDonald, C., Bearne, J., Brown, B., Cheng, A., Humbrecht, C., Tiberghien, P., Ramirez-Arcos, S., & ISBT Transfusion‐Transmitted Infectious Diseases Working Party Subgroup on Bacteria (2025). Platelet component safety in the era of new advancements in bacterial screening and pathogen reduction: A congress report of the 2024 ISBT Transfusion‐Transmitted Infectious Diseases Working Party, Bacteria Subgroup. Vox Sanguinis, 120(8), 846-857. https://doi.org/10.1111/vox.70053
Vancouver
García-Otálora MA, McDonald C, Bearne J, Brown B, Cheng A, Humbrecht C, et al. Platelet component safety in the era of new advancements in bacterial screening and pathogen reduction: A congress report of the 2024 ISBT Transfusion‐Transmitted Infectious Diseases Working Party, Bacteria Subgroup. Vox Sanguinis. 2025;120(8):846-857. doi:10.1111/vox.70053
BibTeX
@article{GarcaOtlora2025,
author = {García-Otálora, Michel-Andrés and McDonald, Carl and Bearne, Jennifer and Brown, Bethany and Cheng, Anthea and Humbrecht, Catherine and Tiberghien, Pierre and Ramirez-Arcos, Sandra and ISBT Transfusion‐Transmitted Infectious Diseases Working Party Subgroup on Bacteria, ISBT Transfusion‐Transmitted Infectious Diseases Working Party Subgroup on Bacteria},
title = {Platelet component safety in the era of new advancements in bacterial screening and pathogen reduction: A congress report of the 2024 ISBT Transfusion‐Transmitted Infectious Diseases Working Party, Bacteria Subgroup},
journal = {Vox Sanguinis},
year = {2025},
volume = {120},
number = {8},
pages = {846--857},
doi = {10.1111/vox.70053}
}
EUVIMED